missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

Gibco™ DMEM, high glucose, no glutamine DFS Item

Used as basal medium for supporting the growth of many different mammalian cells. Gibco™ DMEM, High Glucose, No Glutamine is used in cell culture processing applications.

$58.00 - $590.00

Specifications

Requires: Supplementation


Products 4
Catalog Number Mfr. No. Quantity Price Quantity  
Catalog Number Mfr. No. Quantity Price Quantity  
11960044 DFS Item
View Documents
Gibco™
LS11960044
500mL
Each for $58.00
 
11960051 DFS Item
View Documents
Gibco™
LS11960051
1000mL
Each for $108.00
 
11960069 DFS Item
View Documents
Gibco™
LS11960069
10 x 500mL
Each for $550.00
 
11960077 DFS Item
View Documents
Gibco™
LS11960077
6 x 1000mL
Each for $590.00
 
Description

Description

  • Contains 4 times the concentration of amino acids and vitamins than the original Eagle's Minimal Essential Medium
  • Originally formulated with low glucose (1g/L) and sodium pyruvate, but is often used with higher glucose levels, with or without sodium pyruvate
  • Contains no proteins, lipids, or growth factors
  • Requires supplementation, commonly with 10% Fetal Bovine Serum (FBS)
  • Uses sodium bicarbonate buffer system (3.7g/L), and therefore requires a 5 to 10% CO2 environment to maintain physiological pH
  • Cells successfully cultured in DMEM include primary fibroblasts, neurons, glial cells, HUVECs, and smooth muscle cells, cell lines such as HeLa, 293, Cos-7, and PC-12

Order Info

Shipping Condition: Room Temperature

Compliance

DMEM is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. Class II Device U.S.

Specifications

Specifications

0.0
icon-pdf.png
SDS

When used as a medical device, Federal law restricts this device to sale by or on the order of a physician. Customers using Gibco DMEM in a manufacturing process, who have a submission with the FDA, may request a letter of authorization from Life Technologies to reference their Type II Drug Master File (DMF). For human ex vivo tissue and cell culture processing applications.